Cardiac Rhythm Management Devices | Market Insights | Europe | 2022
Although the COVID-19 pandemic had a negative impact on procedure volumes and market growth in 2020, the European CRM device market will grow modestly over the forecast period. Increasing competition in the leadless pacemaker and S-ICD markets will result in falling prices and the availability of devices with improved quality. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues. The emergence of smart modules for cardiac monitoring will bolster the ICM market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the European CRM device market across an 11-year period.